| Pre-adipocytes |
| Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-l1) |
T4312 |
Male, 23, Caucasian, BMI 24.9 |
|
| Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-l2) |
T4313 |
Female, 38, Caucasian, BMI 24.14, Medication (Levothyrox) |
|
| Human Preadipocytes Subcutaneous, Normal Adult (HPA-n1) |
T4314 |
Female, 48, Caucasian, BMI 26.5 |
|
| Human Preadipocytes Subcutaneous, Normal Adult (HPA-n2) |
T4315 |
Male, 38, Caucasian,BMI 27.7 |
|
| Human Preadipocytes Subcutaneous, Normal Adult (HPA-n3) |
T4316 |
Female, 36, Caucasian, BMI 28.7 |
|
| Human Preadipocytes Subcutaneous, Obese Adult (HPA-o1) |
T4317 |
Female, 58, Caucasian, BMI 30.4 |
|
| Human Preadipocytes Subcutaneous, Obese Adult (HPA-o2) |
T4318 |
Female, 26, Caucasian, BMI 30.5 |
|
| Human Preadipocytes Subcutaneous, Obese Adult (HPA-o3) |
T4319 |
Female, 49, Caucasian, BMI 31.2 |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-Cl1) |
T4320 |
Female, 44, Caucasian, BMI 24.4 |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Lean Adult (BMI ≤25) (HPA-Cl2) |
T4321 |
Female, 60, Caucasian, BMI 24.5 |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Normal Adult (HPA-Cn1) |
T4322 |
Male, 45, Caucasian, BMI 26.6 |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Normal Adult (HPA-Cn2) |
T4323 |
Female, 35, Caucasian, BMI 25.5 |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Adult with Verneuil's Disease (HPA-Cn3) |
T4324 |
Female, 51, Caucasian, Verneuil's Disease, BMI 28.4, Medication (Adepal) |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Obese Adult (HPA-Co1) |
T4325 |
Female, 33, Caucasian, BMI 30.5 |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Obese Adult (HPA-Co2) |
T4326 |
Female, 54, Caucasian, BMI 33.3 |
|
| Human Preadipocytes Subcutaneous - Facial or Eyelid Skin, Normal Adult (HPA-FE) |
T4327 |
Female, 63, Caucasian, BMI 28.3, Medication (Depakote and Deroxat) |
|
| Fully Characterized Human Preadipocytes Subcutaneous, Diabetic Adult (HPA-CD) |
T4328 |
Female, 58, Caucasian, BMI 26.7, Type 2 Diabetes, Medication (Glucophage, Pariet, Simvastatin, and Coveram) |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-73-28.4) |
T4259 |
Female, 73, Caucasian, BMI 28.4, Medication (Metformin, Ozempic, Kardegic, and Cardensiel) |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-69-24.6) |
T4260 |
Female, 69, African, BMI 24.6, Medication (Levothyrox and Kardegic) |
|
| Human Primary Adipose Preadipocyte Cells (Donor M-75-22.3) |
T4261 |
Male, 75, Caucasian, BMI 22.3, Medication (Levothyrox and Metformin) |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-22-22.2) |
T4262 |
Female, 22, Caucasian, BMI 22.2 |
|
| Human Primary Adipose Preadipocyte Cells (Donor M-24-28.7) |
T4263 |
Male, 24, Caucasian, BMI 28.7 |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-24-24.8) |
T4264 |
Female, 24, Caucasian, BMI 24.8 |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-24-27) |
T4265 |
Female, 24, Caucasian, BMI 27.0 |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-66-27) |
T4266 |
Female, 66, Caucasian, BMI 27.0 |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-66-28.6) |
T4267 |
Female, 66, Caucasian, BMI 28.6, Medication (Colpotrophine) |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-21-32.2) |
T4268 |
Female, 21, Caucasian, BMI 32.2 |
|
| Human Primary Adipose Preadipocyte Cells (Donor F-29-29.2) |
T4269 |
Female, 29, Caucasian, BMI 29.2 |
|
| Dermal Fibroblast |
| Human Dermal Fibroblasts - Young(≤25 years) (HDF-y2) |
T4301 |
Male, 23, Caucasian, BMI 24.91 |
|
| Human Dermal Fibroblasts - Normal (26-49 years) (HDF-n1) |
T4302 |
Female, 30, Caucasian, BMI 28.96 |
|
| Human Dermal Fibroblasts - Normal (26-49 years) (HDF-n2) |
T4303 |
Female, 34, Caucasian, BMI 30.1 |
|
| Human Dermal Fibroblasts – Aged (≥50 years) (HDF-a1) |
T4304 |
Female, 66, Caucasian, BMI 27 |
|
| Human Dermal Fibroblasts – Aged (≥50 years) (HDF-a2) |
T4305 |
Female, 56, Caucasian, BMI 21.57 |
|
| Fully Characterized Human Dermal Fibroblasts -Young (≤25 years) (HDF-Cy) |
T4306 |
Female, 21, Caucasian, BMI 32.2 |
|
| Fully Characterized Human Dermal Fibroblasts - Normal (26-49 years) (HDF-Cn1) |
T4307 |
Female, 29, Caucasian, BMI 29.24 |
|
| Fully Characterized Human Dermal Fibroblasts - Normal (26-49 years) (HDF-Cn2) |
T4308 |
Female, 40, Caucasian, BMI 23.0 |
|
| Fully Characterized Human Dermal Fibroblasts – Aged (≥50 years) (HDF-Ca) |
T4309 |
Female, 65, Caucasian, BMI 23.95 |
|
| Human Dermal Fibroblasts - Facial or Eyelid Skin (HDF-FE) |
T4310 |
Female, 70, Caucasian, BMI 23.44 |
|
| Fully Characterized Human Dermal Fibroblasts - Facial or Eyelid Skin (HDF-CFE) |
T4311 |
Female, 46, Caucasian, BMI 20.17 |
|
